ELEVATE (Evaluation of Left Ventricular Autothreshold) 3.0 (ELEVATE 3)
|ClinicalTrials.gov Identifier: NCT01539629|
Recruitment Status : Completed
First Posted : February 27, 2012
Last Update Posted : December 5, 2012
|Condition or disease||Intervention/treatment|
|Heart Failure||Device: Cardiac pacing|
|Study Type :||Observational|
|Actual Enrollment :||50 participants|
|Official Title:||Evaluation of Left Ventricular Autothreshold|
|Study Start Date :||March 2012|
|Actual Primary Completion Date :||June 2012|
|Actual Study Completion Date :||November 2012|
One group reflecting two different pulse widths.
Device: Cardiac pacing
Cadiac pacing via a pulse generator and implaned intracardiac leads.
Other Name: COGNIS PG.
- Collect ventricular evoked response signal and CRT-D device data during LV only and Bi-Ventricular voltage step-down pacing. [ Time Frame: Minimum of 24 hrs post CRT-D implant. ]The primary objective of this study is to collect real-time signals during LV pacing and voltage step-down from patients with implanted COGNIS devices.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01539629
|United States, Iowa|
|Genesis Medical Center|
|Davenport, Iowa, United States, 52803|
|United States, Pennsylvania|
|Cardiology Consultants of Philadelphia|
|Yardley, Pennsylvania, United States, 19067|
|United States, Virginia|
|Virginia Commonwealth University Health System|
|Richmond, Virginia, United States, 23298-0053|
|United States, Wisconsin|
|Wheaton Franciscan Health Care|
|Wauwatosa, Wisconsin, United States, 53226|
|Principal Investigator:||Kenneth L Ellenbogen, MD||Virginia Commonwealth University Health System|